Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$4.95 USD
+0.10 (2.04%)
Updated Aug 23, 2024 03:48 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -3.00 |
EPS Last Quarter | -2.89 |
Last EPS Surprise | 4.62% |
ABR | 1.00 |
Earnings ESP
|
13.00% |
---|---|
Current Year | -11.40 |
Next Year | -9.19 |
EPS (TTM) | -12.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.24M | 0.24M | 1.69M | 0.70M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 0.28M | 0.28M | 1.92M | 0.80M |
Low Estimate | 0.20M | 0.20M | 1.37M | 0.60M |
Year ago Sales | 0.18M | 0.30M | 0.79M | 1.69M |
Year over Year Growth Est. | 33.33% | -20.00% | 114.78% | -58.48% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.00 | -2.72 | -11.40 | -9.19 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -2.61 | -2.26 | -11.43 | -8.12 |
High Estimate | -2.61 | -2.26 | -10.43 | -8.12 |
Low Estimate | -3.22 | -3.47 | -12.43 | -10.25 |
Year ago EPS | -3.40 | -3.11 | -13.43 | -11.40 |
Year over Year Growth Est. | 11.76% | 12.54% | 15.12% | 19.43% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.00 | -2.72 | -11.40 | -9.19 |
7 Days Ago | -3.00 | -2.72 | -11.40 | -9.19 |
30 Days Ago | -3.04 | -2.76 | -11.63 | -9.42 |
60 Days Ago | -3.04 | -2.76 | -11.63 | -9.42 |
90 Days Ago | -2.57 | -2.40 | -10.12 | -8.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.61 | -2.26 | -11.43 | -8.12 |
Zacks Consensus Estimate | -3.00 | -2.72 | -11.40 | -9.19 |
Earnings ESP | 13.00% | 17.01% | -0.26% | 11.60% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.89 | -2.83 | -3.11 | -3.40 | NA |
Estimate | -3.03 | -2.88 | -3.09 | -3.00 | NA |
Difference | 0.14 | 0.05 | -0.02 | -0.40 | -0.06 |
Surprise | 4.62% | 1.74% | -0.65% | -13.33% | -1.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more